Intrahepatic Cholangiocarcinoma — Trials

Intrahepatic Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 88
Recruiting: 53
Ph III recruiting: 2
Growth YoY: +23.8%
Industry share: 9%
Top sponsor: Fudan University
Termination share: 47.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04782804	Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence	unknown	Phase 1 / Phase 2	30	Fudan UniversityOTHER	1	Aug 18, 2022	clinicaltrials
NCT03633773	Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma	unknown	Phase 1 / Phase 2	9	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Aug 22, 2018